CAS: 55837-25-7; Buflomedil

该化合物是一种主要用作血管血管药物的药物化合物,这意味着它有助于扩大血管,改善血液流动;它经常用于治疗外围血管疾病,特别是在血液循环受损的情况下;Buflomediel行为,抑制重新服用新肾上腺素,加强释放某些...

结构式图片

合成工艺路线路线简述

    📜1,3,5-三甲氧基苯,γ-丁内酯,四氢吡咯 反应生成 丁洛地尔
    参考文献:Mimori,Nobuo;Okubo,Takasi;Oxara,Tsugio;Aoki,Tomiesi
    标题:Mimori,Nobuo;Okubo,Takasi;Oxara,Tsugio;Aoki,Tomiesi

    海关参考信息

    专利信息


    专利号:US-8354116-B2
    优先权日:2007-06-18
    标题 :Bifunctional synthetic molecules
    发明人:CARTER STEPHEN G; PATEL KANU; ZHU ZHEN; QIAO LIXIN
    权利人:BIOCHEMICS INC; CARTER STEPHEN G; PATEL KANU; ZHU ZHEN; QIAO LIXIN
    摘要:The synthesis and use of bifunctional molecules to improve the topical and transdermal delivery efficiency of various types of therapeutic agents or agents designed to promote the transdermal delivery of those therapeutic agents either into the skin tissue or into the systemic circulation. Three major classes of molecules are covalently joined as bifunctional substances; chemical vasodilators, passive dermal penetration enhancers and therapeutic or diagnostic drugs. Chemical vasodilators may be delivered into the skin to increasing the blood flow in a tissue that has compromised circulation or they may be used as part of a delivery vehicle to promote the delivery of the drug. Passive dermal penetration enhancers are those chemicals that promote the passive penetration of drugs and other chemicals through the stratum corneum and epidermis of the skin tissue. Drugs and diagnostic agents are the third group of chemicals that are candidates for the linkage of molecules.

    专利号:IT-1262955-B
    优先权日:1992-07-07
    标 题:NEW FAMILY OF MOLECULES, ORIGINAL COMPOUNDS OF SYNTHESIS BETWEEN 2-0X0-1-PYRROLIDINEACETAMIDE AND 4- (1-PYRROLIDINYL) -1- (2,4,6, -TRIMETOXYPHENYL) - 1-BUTANONE.

    专利号:CN-109369350-B
    优先权日:2018-11-23
    标题 :Synthesis method of buflomedil hydrochloride intermediate 1,3, 5-trimethoxybenzene

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: de Backer TL, Vander Stichele R. Buflomedil for intermittent claudication. Cochrane Database Syst Rev. 2013 Mar 28;(3):CD000988. doi: 10.1002/14651858.CD000988.pub4. Review. doi: 10.1002/pds.3328. Epub 2012 Jul 31. Review. doi: 10.1002/14651858.CD009570.pub2. Review. doi: 10.4103/0253-7613.99312.
    9: Kushiku K, Ohba M, Mikagi T, Nuki S, Araki Y, Furukawa T. Cardiovascular actions of buflomedil and possible mechanisms involved. Arzneimittelforschung. 1989 Jun;39(6):670-7. doi: 10.1002/14651858.CD000988.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;3:CD000988. Review. Chinese.

    合成参考文献


    摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
    摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664
    参考文献:10.1007/bf01728332
    摘要:Legras A, Piquemal R, Furet Y, Dequin PF, Perrotin D. Buflomedil poisoning: five cases with cardiotoxicity. Intensive Care Med. 1996 Jan;22(1):57–61. doi: 10.1007/bf01728332.
    摘要:Migdalis IN, Varvarigos N, Charalabides J, Leontiades E, Gerolimou B, Mantzara F, Karmaniolas K. Effects of buflomedil on early carotid atherosclerosis in Type 2 diabetic patients. Int Angiol. 2001 Jun;20(2):126–30.
    参考文献:10.1016/j.bjps.2005.07.005
    摘要:Mauad RJ, Shimizu MHM, Mauad T, de Tolosa EMC. Buflomedil and pentoxifylline in the viability of dorsal cutaneous flaps of rats treated with nicotine. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2006 Apr;59(4):387–92. doi: 10.1016/j.bjps.2005.07.005.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知